QPS Austria

QPS Austria is well-known as a leading preclinical and clinical CRO for CNS and rare disease drug discovery and development. 

QPS Austria performed hundreds of efficacy and proof-of-concept studies with a wide range of transgenic in vivo models for neurodegenerative and rare diseases and clinical studies in different phases with thousands of patients. In preclinical projects you will benefit from the experience gained during projects with virtually all drug targets in neurodegenerative and rare diseases. Extensive behavioral, histological and biochemical evaluations will meet your high expectations in terms of precision, quality and timely delivery of your custom built research.